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in immunocompromised patients. However, it can be seen in association with other bacteria, viruses, and
fungi. We report a case of a 54-year-old African American female with metastatic gastric adenocarcinoma
and recent chemotherapy and neutropenia who developed EG-like lesions due to methicillin-susceptible
Staphylococcus aureus. We also review the literature to evaluate all reported cases of S aureus-associated
EG and their clinical presentation, diagnosis, and treatment.
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Ecthyma gangrenosum (EG) is a well-described skin manifesta-
tion of Pseudomonas aeruginosa septicemia in immunocompromised
patients. EG is most commonly seen in Pseudomonas septicemia.
However, it may be seen in association with infections caused by
other gram-negative bacteria and fungi and can rarely be caused by
gram-positive organisms such as Staphylococcus and Streptococcus
species. We report a case of a 54-year-old African American female
with neutropenia in the setting of metastatic gastric adenocarcinoma
and recent chemotherapy who developed EG-like lesions due to
methicillin susceptible Staphylococcus aureus. In addition, we also re-
view the literature and discuss all reported cases of S aureus-
associated EG manifestation, diagnosis, and treatment.Case report
A54-year-old African American femalewith amedical history sig-
niﬁcant for systemic lupus erythematosus on chronic therapy with
systemic steroids and hydroxychloroquine was recently diagnosed
with gastric adenocarcinoma with metastatic liver lesions. She pre-
sented to our hospital with fever and painful skin lesions. The patient
had received a ﬁrst round of chemotherapy with 5-ﬂuorouracil, cis-
platin, and trastuzumab. Seven to ten days after the last dose of che-
motherapy she noted multiple painful skin lesions.nc. on behalf of Women's DermatOn admission, the patient’s blood pressure was 86/52 mmHg,
heart rate 122 bpm, and temperature 103.7 °F. The patient was
alert, oriented, and not in any acute distress. Skin examination re-
vealed three 3-12–mm, tender, indurated, and erythematous papules
and plaqueswith violaceous-gray centers located on the left popliteal
fossa, right anterolateral knee, and right external ear canal. Addition-
ally, there were 4-5–mm vesicles at the right mandibular angle and
right arm, and pustules scattered on themid chest (see Figs. 1 and 2).
Admission laboratory studies revealed pancytopenia and elevated
erythrocyte sedimentation rate and C-reactive protein. Additional re-
sults are shown in Table 1.
Three sets of blood cultures obtained prior to administration of
antibiotic therapy showed no growth. Fungal blood cultures were
negative. Chest imaging did not reveal any pathology. Transthoracic
and transesophageal echocardiograms showed normal valvular func-
tion without vegetations.
The patient’s initial therapywith intravenous cefepime, vancomycin,
and metronidazole was changed to intravenous acyclovir, vancomycin,
and double pseudomonas coverage with meropenem and amikacin
after evaluation by the infectious disease and dermatology teams.
Cutaneous punch biopsies were obtained from the violaceous-
gray lesion on the left popliteal fossa and a pustule from the chest.
Histopathology of the violaceous-gray lesion revealed prominent
edema and numerous gram-positive cocci in the superﬁcial dermis
(see Figs. 3 and4). Additionally, therewas a perivascular inﬂammato-
ry cell inﬁltrate in the superﬁcial and deep dermis composed of lym-
phocytes, histiocytes, and neutrophils, aswell as dilated blood vessels
with extravasated erythrocytes. Special stains for acid fast bacilli and
fungal organisms were negative. The chest pustule histologicallyologic Society. This is an open access article under the CC BY-NC-ND license (http://
Fig. 2. Indurated, erythematous plaque with central edema.
Fig. 1. Indurated, erythematous papule with violaceous-grey center.
Table 1
Blood Test Performed on Admission.
Blood test Patient’s
results
Normal reference
range
White blood cell count 0.8 × 103/uL 3.6-11.0 × 103/uL
Absolute neutrophil count 0.4 × 103/uL 1.4-6.3 × 103/uL
Platelet count 78 × 103/uL 150-440 × 103/uL
Hemoglobin 7.7 g/dL 12.0-16.0 g/dL
Erythrocyte sedimentation rate 150 mm/h 0-20 mm/h
C- reactive protein 132.9 mg/L b1.0 mg/L
Creatinine 0.9 mg/dL 0.6-1.2 mg/dL
Blood urea nitrogen 10 mg/dL 8-24 mg/dL
Beta-D glucan 31 pg/mL b31 pg/mL is negative,
N80 pg/mL positive
Aspergillus Galactomannan
index by EIA
0.08 index equal to or
greater than 0.5 positive
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positive cocci. Tissue cultures from both specimens grew
methicillin-susceptible Staphylococcus aureus, with an oxacillin
minimum inhibitory concentration of 0.5 mcg/ml.
Acyclovir, meropenem, and vancomycin were discontinued. All
blood cultures remained negative throughout hospitalization, and
the patientwas discharged home to complete 2weeks of intravenous
oxacillin.
Discussion
Ecthyma gangrenosum (EG) is a well-described skin manifesta-
tion of P aeruginosa septicemia in immunocompromised patients.
EG lesions usually are round, indurated, ulcerated papules
progressing into plagues with a central gray-black eschar and sur-
rounding erythema. Lesions may evolve from initial vesiculobullous
lesions and rapidly become hemorrhagic.
The clinical differential diagnosis in our case included EG associat-
ed with invasive pathogens: Pseudomonas, Staphylococcus sp., fungal
infection such as Aspergillus sp., Fusarium sp., disseminated varicella
zoster virus, and herpes simplex virus; noninfectious entities such
as vasculitis were also considered. Ecthyma (“deep impetigo”) was
not considered in our differential diagnosis, as clinically the skin
lesions in our patient did not start as superﬁcial epidermal
erosions and crusting that progressed deeper into the dermis to
create crusted ulcers.
EG is most commonly seen in Pseudomonas septicemia; however,
it may be seen in association with infections caused by other gram-
negative bacteria, such as Aeromonas hydrophilia, Klebsiella pneumo-
nia, Escherichia coli, Neisseria gonorrhea, Citrobacter freundii, Serratiamarcescens, and fungi including Candida albicans, Aspergillus
fumigatus, Fusarium solani, Pseudallescheria boydii and Curvularia sp.
The viral pathogens herpes simplex viruses 1 and 2 and varicella-
zoster virus can be associated with EG as well. Rarely, EG can be
caused by gram-positive organisms such as Staphylococcus and Strep-
tococcus species (Kao et al. 2001; Reich et al. 2004).
A reviewof English literature in PubMed between January 1, 1990,
to January 31, 2016, was performed using the following keywords:
non-pseudomonal ecthyma gangrenosum, methicillin-resistant
Staphylococcus aureus, and methicillin-susceptible Staphylococcus
aureus. This search revealed 5 other reported cases of EG associated
with S aureus infection. EG usually occurs in the patients with under-
lying immunodeﬁciency. Predisposing factors include neutropenia,
Fig. 3. Prominent superﬁcial dermal edema and a dense perivascular inﬂammatory in-
ﬁltrate with neutrophils.
Fig. 4. Numerous gram-positive cocci in the upper dermis.
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tients described in the literature had underlying immunosuppression
(Song et al. 2015).
EG can occur in association with bacteremia or in patients with
sterile blood cultures (Huminer et al. 1987; Reich et al. 2004). Skin le-
sions in patients with bacteremia represent hematogenous dissemi-
nation of organisms from distant sites, and blood cultures are
positive in these patients. In those patientswith sterile blood cultures
and EG, skin lesions are thought to be associatedwith direct pathogen
inoculation into the skin. However, as previously discussed, this
would not explain the simultaneous presence of multiple discrete,
distant skin lesions. Blood cultures were negative in ﬁve out of six re-
ported Staphylococcus cases, including our case (Table 2). Our patient
had multiple sterile blood cultures but had organisms cultured from
three different skin lesions. This could be explained by transient bac-
teremia that was undetected in cultures. Interestingly, in the case
presented by Song et al., organisms were not found in tissue stains,
and skin lesions were therefore thought to be associated with toxins
produced by S aureus (Song et al. 2015). However, Staphylococcus
was cultured from tissue culture.
Upon review of all published case reports, methicillin resistance
wasmore commonly associatedwith EG lesions, as only two patients
out of six had methicillin-susceptible Staphylococcus cultured from
skin lesions. Lesions had a wide anatomic distribution but were
more commonly seen on the trunk and upper and lower extremities
and less commonly on the face. Lesions may be macular, papular,
plaque-like, ulcerated, bullous, and/or vesicular. All lesions had
necrotic-appearing centers with surrounding erythema and soft tis-
sue induration (see Table 2).
Histopathologic evaluation of skin biopsies revealed dermal
edema with neutrophil inﬁltration and gram positive cocci in most
of the reported S aureus–associated cases. Extensive dermal and epi-
dermal necrosis was reported only in 2 cases (Table 2). Histopatho-
logic evaluation of skin biopsies from our patient did not reveal the
typical ﬁndings of EG, such as blood vessel invasion, vasculitis, and
necrosis. However, given the wide anatomic distribution of multiple
skin lesions, typical clinical appearance and systemic symptoms
that are not generally seen with deep impetigo, the lesions in our pa-
tient are most consistent with EG.
As opposed to other infections caused by S aureus, written treat-
ment guidelines for staphylococcal EG do not exist. Given skin and
soft tissue involvement, one could consider treating patients based
on Skin and Soft Tissue Infection Guidelines (Liu et al. 2011), whichwould comprise 5 to 10 days of therapy, individualizing based on
the patient’s clinical response. Clindamycin, trimethoprim-
sulfamethoxazole, tetracycline (doxycycline or minocycline), or li-
nezolid could be used to treat methicillin-resistant S aureus infection
(Liu et al. 2011). For methicillin-susceptible strains, dicloxacillin,
cephalexin, nafcillin, or cefazolin can be employed.
In a hospitalized patient, especially in patients with febrile neu-
tropenia and complicated skin and soft tissue infections, surgical de-
bridement plus intravenous antibiotic therapy is recommended.
According to the Skin and Soft Tissue Infection Guidelines, treatment
duration in febrile neutropenic patients should be 7 to 14 days with
intravenous therapy. Given the wide distribution of skin lesions and
possibility of disseminated infection, we recommend that treatment
be prolonged to the duration recommended to treat noncomplicated
blood stream infections.
Treatment should be initiated with intravenous vancomycin, dap-
tomycin, cefazolin, nafcillin, or oxacillin for at least 2 weeks depending
on the susceptibility pattern for uncomplicated bacteremia (Liu et al.
2011; Stevens et al. 2014). Empiric therapywith broader spectrum an-
tibiotics, such as vancomycin, daptomycin, or linezolid should be con-
sidered pending culture data. Duration of the pathogen-directed
therapy in case reports ranged from 14 to 28 days, with intravenous
as opposed to oral therapy being the delivery of choice (Song et al.
2015). Our patient received 2 weeks of intravenous oxacillin.Conclusion
EG is most commonly seen in septicemia caused by P aeruginosa
in an immunocompromised host. However, in the presence of neu-
tropenia and immunosuppression, EG lesions can be caused by
gram-positive bacteria such as S aureus. These patients may have
negative blood cultures. Gram positive coverage should be consid-
ered early in patients without clinical improvement.Conﬂicts of interest
noneFunding
none
Table 2
Case Reports of Patients with Staphylococcus aureus Ecthyma Gangrenosum.
Author
(location)
Song et al. 2015 (PA) Sen et al. 2009
(Turkey)
Ungprasert
et al. 2013
(Japan)
Chang et al. 2012 (PA) Pechter et al. 2012 (FL) UCONN, 2015 (CT)
Our reported case.
Underlying
medical
condition
Healthy 15-month- old girl 69-year-old male
with COPD
40 year old
with AIDS,
MRSA skin
abscess 2
weeks prior
the admission
35 year old with T-cell
ALL, with recent
chemotherapy (2
weeks prior)
8-month-old infant with
transient neutropenia
54-year-old female with
SLE and metastatic gastric
adenocarcinoma with
recent chemotherapy (7-10
days prior)
MRSA vs MSSA MSSA MRSA MRSA MRSA MRSA MSSA
Blood cultures
positive (+)
vs negative
(–)
(–) (+) (–) (–) (–) (–)
Lesion cultures
(+) vs
(–):GS: HP
Culture: MSSA Cultures MRSA Culture:
negative
Culture: MRSA Culture: MRSA (tissue) Culture MSSA
GS: no organism GS: NR GS: NR GS: GPC in clusters GS: NR GS: GPC
HP: no organism HP: NR HP: NR HP: NR HP: NR HP: GPC
(cultures from
prior skin
abscess
+MRSA)
Location of the
lesion(s)
Chest, axilla, and shoulders Upper and lower
extremities
Trunk, lower
extremities
Buttocks, bilateral
upper thighs, lower
abdomen
Face, neck, back, genitalia Face, upper and lower
extremities, trunk
Description of
the lesion
Eight purpuric, indurated
plaques and nodules with
ovoid necrotic centers
Macular lesions
evolved to bullae
over the 3 days
with necrotic
center and
surrounding
erythema
Multiple deep,
punched-out
ulcerations
with necrotic
base and
surrounding
erythema
Tender hemorrhagic
bullae with
surrounding erythema
Edematous papules,
purplish-red with necrotic
centers
Multiple vesicular lesions,
necrotic macules, gunmetal
gray color, indurated,
tender with erythematous
soft tissue edema
surrounding the central
necrosis
Histopathology Dyskeratotic keratinocytes
and focal spongiosis of the
epidermis. Dermal inﬁltration
with neutrophils,
lymphocytes and
karyorrhectic debris
surrounding dermal blood
vessels
No biopsy
performed
No biopsy
performed
Numerous bacteria in
the dermis without
inﬂammatory
inﬁltrate, and with
dermal/epidermal
edema, necrosis, and
hemorrhages
Large vessel vasculitis in
the superﬁcial subcutis, foci
of dermal necrosis with
overlying epidermal
necrosis with bullae, and
numerous gram-positive
cocci
Necrotic eschar: edema,
dilated blood vessels and
superﬁcial inﬁltrates of
lymphocytes, histiocytes,
and neutrophils were
present within dermis
Vesicular lesion:
intraepidermal pustular
dermatitis with gram-
positive cocci
Treatment and
duration
14 days of IV therapy with
doxycycline, followed by PO
cephalexin
Ampicillin/
sulbactam
Linezolid 4
weeks PO
Vancomycin IV,
(duration not
reported)
Vancomycin IV 14 days Vancomycin+ nafcillin
total 2 week IV therapy
+ meropenem Initial antibiotic therapy
(vancomycin, cefepime,
amikacin)
Initial antibiotic therapy
(vancomycin, meropenem,
amikacin, acyclovir)
+ teicoplanin IV
Outcome Was discharged Died—septic
shock
Was
discharged
Was discharged Was discharged Was discharged
COPD, chronic obstructive pulmonary disease; MRSA, methicillin resistant Staphylococcus aureus; ALL, acute lymphoblastic leukemia; SLE, systemic lupus erythematosus;
MSSA, methicillin sensitive Staphylococcus aureus; GS, gram stain; HP, histopathology stain; NR, not reported; GPC, gram positive cocci; IV, intravenous; PO, oral administration
of medication.
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